Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Dermatology Service"
  3. "Survivorship Research"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (17)
  2. Dermatology (17)
  3. Dermatology Service (17)
  4. Division of Subspecialty Medicine (17)
  5. Nursing (17)
  6. Survivorship Research (17)

More Groups

People
  1. Allan Halpern (9)
  2. Deborah Phelan (8)
  3. Patricia Myskowski (7)
  4. Alison Moskowitz (6)
  5. Stephen Dusza (6)
  6. Steven Horwitz (6)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (2)
  6. 2014 (1)

More Years

Publications
  1. Blood (2)
  2. Journal of Clinical Oncology (2)
  3. Journal of Investigative Dermatology (2)
  4. American Journal of Hematology (1)
  5. American Journal of Preventive Medicine (1)
  6. British Journal of Dermatology (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (3)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. American Society of Hematology (2)
  5. A.J. Jannetti (1)
  6. Blackwell Publishing (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients
    Journal Article

    Gu, S.; Menzer, C.; Hay, J. L.; Pena, C.; Dusza, S.; Lacouture, M. E.; Markova, A.
    Supportive Care in Cancer (2023)

    Fulltext@MSK | Save
  • Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
    Journal Article

    Mehta-Shah, N.; Lunning, M. A.; Moskowitz, A. J.; Boruchov, A. M.; Ruan, J.; Lynch, P.; Hamlin, P. A.; Leonard, J.; Matasar, M. J.; Myskowski, P. L.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas
    Meeting Abstract

    Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results
    Meeting Abstract

    Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption
    Journal Article

    Scope, A.; Lieb, J. A.; Dusza, S. W.; Phelan, D.; Myskowski, P.; Saltz, L.; Halpern, A. C.
    Journal of the American Academy of Dermatology (2009)

    Fulltext@MSK | Save
  • Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma
    Journal Article

    Hay, J. L.; Oliveria, S. A.; Dusza, S. W.; Phelan, D. L.; Ostroff, J. S.; Halpern, A. C.
    Cancer Epidemiology Biomarkers and Prevention (2006)

    Fulltext@MSK | Save